Zientzia eta Teknologia Fakultateko IV. Ikerkuntza Jardunaldiak

[EU]I. Abstracts. Ahozko komunikazioak 1. Biozientziak: Alderdi Molekularrak 2. Biozientziak: Ingurune Alderdiak. 3. Fisika eta Ingenieritza Elektronika 4. Geología 5. Matematika 6. Kimika 7. Ingenieritza Kimikoa eta Kimika II. Abstracts. Idatzizko Komunikazioak (Posterrak) 1. Biozientziak 2. Fisika eta Ingenieritza Elektronika 3. Geologia 4. Matematika 5. Kimika 6. Ingenieritza Kimikoa

Ramon Saizarbitoriaren nobelagintza memoria ikasketen ikuspegitik

373 p.

Paleoambiente y antropización en los Pirineos de Navarra durante el Holoceno medio (VI-IV PDF milenios cal. BC): Una perspectiva palinológica

Homenaje a Ignacio Barandiarán Maestu / coord. por Javier Fernández Eraso, Juan Santos Yanguas

Aristóteles, «Poética» 1454a 24, y la tragedia del siglo IV

[ES] La cualidad de "semejantes", el requisito que Aristóteles señala han de poseer los personajes de la tragedia en «Poét.» 1454a 24, ha recibido fundamentalmente dos interpretaciones distintas. Una, la que supone que tal semejanza lo es con el hombre ordinario, está bien asentada dentro de la argumentación general de la «Poética»; la otra, que relaciona el concepto con el prototipo mítico, requiere más aclaraciones que la anterior si se pretende que pueda ser aristotélica. De ello nos ocupamos en el presente artículo, poniendo en relación la práctica contemporánea, la tragedia del siglo IV, con las opiniones de Aristóteles en la «Poética».

Dipeptidyl-Peptidase IV Activity Is Correlated with Colorectal Cancer Prognosis

Background Dipeptidyl-peptidase IV (EC 3.4.14.5) (DPPIV) is a serine peptidase involved in cell differentiation, adhesion, immune modulation and apoptosis, functions that control neoplastic transformation. Previous studies have demonstrated altered expression and activity of tissue and circulating DPPIV in several cancers and proposed its potential usefulness for early diagnosis in colorectal cancer (CRC). Methods and principal findings The activity and mRNA and protein expression of DPPIV was prospectively analyzed in adenocarcinomas, adenomas, uninvolved colorectal mucosa and plasma from 116 CRC patients by fluorimetric, quantitative RT-PCR and immunohistochemical methods. Results were correlated with the most important classic pathological data related to aggressiveness and with 5-year survival rates. Results showed that: 1) mRNA levels and activity of DPPIV increased in colorectal neoplasms (Kruskal-Wallis test, p<0.01); 2) Both adenomas and CRCs displayed positive cytoplasmic immunostaining with luminal membrane reinforcement; 3) Plasmatic DPPIV activity was lower in CRC patients than in healthy subjects (Mann-U test, p<0.01); 4) Plasmatic DPPIV activity was associated with worse overall and disease-free survivals (log-rank p<0.01, Cox analysis p<0.01). Conclusion/significance 1) Up-regulation of DPPIV in colorectal tumors suggests a role for this enzyme in the neoplastic transformation of colorectal tissues. This finding opens the possibility for new therapeutic targets in these patients. 2) Plasmatic DPPIV is an independent prognostic factor in survival of CRC patients. The determination of DPPIV activity levels in the plasma may be a safe, minimally invasive and inexpensive way to define the aggressiveness of CRC in daily practice.